title: [Fibrates].
abstract: Although fibrates was a medicine with a long history, at the clinical spot, the profitability had not permeated as compared with statin. However, many-sided effects, such as a fall of a cardiovascular event and control of arteriosclerosis prevention and a diabetic microangiopathy, were reported as a result of the large-scale clinical test in recent years. Accumulation of the further clinical evidence of a fibrates is expected.
authors.affiliation: Division of Cardiovasucular Medicine, Department of Internal Medicine, Toho University Omori Medical Center.
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Hara
authors.forename: Junichi
authors.initials: J
authors.lastname: Yamazaki
mesh_terms: D001161:Arteriosclerosis / Q000188:drug therapy; D058607:Fibric Acids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents